Drugs & Targets Fate Therapeutics completes technology transfer and starts IND-enabling manufacture of FT500 December 15, 2017Vol.43 No.46
Drugs & TargetsFree Whole genome sequencing center established in Singapore December 09, 2017Vol.42 No.45
Drugs & TargetsFree Amgen and Allergan seek EMA approval of biosimilar bevacizumab December 09, 2017Vol.42 No.45
Drugs & TargetsFree EC Grants Conditional Approval for AbbVie’s Venclyxto for CLL December 09, 2017Vol.42 No.45
Drugs & Targets FDA approves adjuvant indication for Sutent in renal cell carcinoma December 07, 2017Vol.40 No.10
Drugs & Targets FDA approves Ogivri, first biosimilar for treating breast and stomach cancers December 01, 2017Vol.43 No.44
Drugs & Targets Tesaro receives European approval of Zejula for recurrent ovarian cancer December 01, 2017Vol.43 No.44
Drugs & Targets G1 Therapeutics and AstraZeneca enter clinical trials collaboration in NSCLC December 01, 2017Vol.43 No.44
Drugs & Targets ITUS Corp. Moffitt enter into CRADA to develop CAR-T technology December 01, 2017Vol.43 No.44
